World Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on World Wellness Times.

Press releases published on June 1, 2026

Jun. 1, 2026

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026

Indeterminate GlobeNewswire

Jun. 1, 2026

Teva to Present at the Goldman Sachs Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 1, 2026

Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

CorVel Appoints Sarah Scott CEO and President; Michael G. Combs to Transition to Executive Chair

Indeterminate GlobeNewswire

Jun. 1, 2026

Praxis Precision Medicines Provides Vormatrigine Program Update

Indeterminate GlobeNewswire

Jun. 1, 2026

UroGen Pharma to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 1, 2026

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis

Indeterminate GlobeNewswire

Jun. 1, 2026

Abivax annonce des résultats majeurs de l’essai de maintenance de phase 3 ABTECT évaluant l’obéfazimod dans le traitement de la rectocolite hémorragique active modérée à sévère

Indeterminate GlobeNewswire

Jun. 1, 2026

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs

Indeterminate GlobeNewswire

Jun. 1, 2026

Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio

Indeterminate GlobeNewswire

Jun. 1, 2026

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review

Indeterminate GlobeNewswire

Jun. 1, 2026

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 1, 2026

Keros Therapeutics Announces Participation at Goldman Sachs 47th Annual Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 1, 2026

Cardiff Oncology to Participate in the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire

Jun. 1, 2026

Exicure Announces Receipt of Nasdaq Delinquency Notice and Filing of Form 10-Q

Indeterminate GlobeNewswire

Jun. 1, 2026

Fourfront Contributor launches ‘Return on Response’ campaign to highlight value of behavioral health and law enforcement crisis response partnerships

Indeterminate GlobeNewswire